VHB Lifesciences
VHB Life Sciences
VHB Life Sciences
VHB Lifesciences VHB Lifesciences VHB Lifesciences VHB Lifesciences VHB Lifesciences VHB Lifesciences VHB Lifesciences VHB Lifesciences VHB Lifesciences
VHB Lifesciences VHB Lifesciences VHB Lifesciences VHB Lifesciences

Our Products

VHB Lifesciences
api
VHB Lifesciences
VHB Lifesciences
Formulation
VHB Lifesciences
VHB Lifesciences
Field Force
VHB Lifesciences
VHB Lifesciences

Company Video

VHB Lifesciences
Home » Our Products » Therapeutic Segmentation » Oncology
« Previous  1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9  Next »

Oncology

We supply variety of breast cancer injection, cervical cancer medicine, kaposi's sarcoma medicine, lung cancer medicine, ovarian cancer medicine etc.

Procarb

Procarb Generic:
procarbazine

classification:
alkylating agent

composition:
each capsules contains 50mg of procarbazineas procarbazine hydrochloride

mechanism of action:
it inhibits incorporation of small dna precursors, as well as rna and protein synthesis. Procarbazine can also directly damage dna through an alkylation reaction. Procarbazine is not cross-resistant with other alkylating agents and is cell cycle phase-specific (s-phase).

indications:
  • hodgkin's lymphoma
  • brain tumor
  • non-hodgkin's lymphoma.


storage:
tight, light-resistant containers at 15-30ºc (may be exposed to =40ºc).

strengths:
  • procarb cap 50 mg

ADROSAL 10 MG LYOPHILISED VIAL

ADROSAL 10 MG LYOPHILISED VIAL GENERIC:
DOXORUBICIN
COMPOSITION:
Each Vial contains:
Lactose ……q.s.

MECHANISM OF ACTION:
Doxorubicin damages DNA by intercalation of the anthracycline portion, metal ion chelation, or by generation of free radicals. Doxorubicin has also been shown to inhibit DNA topoisomerase II that is critical to DNA function. Cytotoxic activity is cell cycle phase-nonspecific.

INDICATION:
  • Acute lymphoblastic leukemia
  • Acute myeloblastis leukemia
  • Acute non-lymphoblastic leukemia
  • Breast cancer
  • Hodgkin's lymphoma
  • Small cell lung cancer
  • Non-Hodgkin's lymphoma
  • Ovarian cancer
  • Ewing's sarcoma

STORAGE:
  • Store powder at room temperature.

CYBIN PF INJ 100MG/mL

CYBIN PF INJ 100MG mL GENERIC:
CYTARABINE, CYTOSINE ARABINOSIDE (Ara-C)

CLASSIFICATION:
Antimetabolite

COMPOSITION:
Each ml contains Cytrabine ………….100mg.

MECHANISM OF ACTION:
Its mode of action is due to its rapid conversion into cytosine arabinoside triphosphosphate, which damages DNA when the cell cycle holds in the S phase (synthesis of DNA). Rapidly dividing cells, which require DNA replication for mitosis, are therefore most affected. Cytosine arabinoside also inhibits both DNA and RNA polymerases and nucleotide reductase enzyme needed for the DNA synthesis. Cytarabine is rapidly deaminated in the body into the inactive uracil derivative form and therefore, it is often given by continuous intravenous infusion.

INDICATION:
  • Acute myelogenous leukemia
  • Meningeal leukemia
  • Chronic myelogenous leukemia
  • Erythroleukemia
  • Non-Hodgkin's lymphoma.

STORAGE:
  • Store below 25°C

Dacmozen

Dacmozen generic:
dactinomycin, actinomycin
composition:
each vial contains
dactinomycin……. . 5mg

mechanism of action:
it is belived to produce its cytotoxic affects by binding dna & inhibiting rna synthesis. It also causes intercalation preferentially with guanine base pairs. Thus act as a potent inhibitor of rna.

indications:
  • ewing's sarcoma
  • rhabdomyosarcoma
  • testicular cancer
  • choriocarcinoma
  • wilm's tumour

strength:
  • dacmozen inj 0. 5 mg

storage:
  • store in a cool and dry, protect from light.

EPICIN 10 mg/10ml

EPICIN 10 mg 10ml GENERIC:
EPIRUBICIN
MECHANISM OF ACTION:
It intercalates into DNA, which results in inhibition of DNA synthesis and function. It inhibits Topoisomerase II by forming a cleavable complex with Topoisomerase II and DNA. It is also involved in oxidation/reduction reactions by generating cytotoxic oxygen free radicals, which can cause single & double-stranded DNA breaks.

COMPOSITION:
Each vial contains:Epicin 10mg
Epirubicin Hydrochloride B.P.……..10mg
Methyl Paraben I.P…..2mg
Lactose I.P. ……..q.s.
Each vial contains: Epicin 50mg
Epirubicin Hydrochloride B.P.……..50mg
Methyl Paraben I.P…..20mg
Lactose I.P. ……..q.s.

INDICATIONS:
Epirubicin is recommended for the treatment of metastatic breast cancer. Epirubicin may also be used as a component in the adjuvant treatment of early stage breast cancer for pre- and peri- menopausal women.

Looking for Product Name ?